Robert Mabry

Company: Orna Therapeutics

Job title: Chief Scientific Officer

Seminars:

Industry Leader’s Fireside Chat: Supercharging In Vivo as the Frontier of Cell Therapy & Comparing to Ex Vivo 9:00 am

Accentuating the bottlenecks of ex vivo therapies, such as the need for costly manufacturing processes and limited access, to consider the need to move towards a new engineering technique Championing in vivo therapies by highlighting the solutions they could bring to the ex vivo cell therapy and gene editing field Reaffirming the shift of interest…Read more

day: Conference Day One